Zentalis Pharmaceuticals furnishes August 2023 corporate presentation; no material new data disclosed

Zentalis Pharmaceuticals, Inc.

No earnings, guidance, or clinical data included in the 8-K filing.
Corporate presentation dated August 2023; content not fully provided here.
No changes to executive leadership, capital structure, or business strategy.

item 7.01 item 9.01

Zentalis Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001725160-23-000157

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.